High expression of OX40 (CD134) and 4-1BB (CD137) molecules on CD4+CD25high cells in children with type 1 diabetes
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference24 articles.
1. Incidence trends for childhood type 1 diabetes in Europe during 1989–2003 and predicted new cases 2005–20: a multicentre prospective registration study;Patterson;Lancet,2009
2. Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes;Pop;J Exp Med,2005
3. In vivo control of diabetogenic T-cell by regulatory CD4+CD25+ T-cells expressing foxp3;Lundsgaard;Diabetes,2005
4. Immune regulation and control of regulatory T cells by OX40 and 4-1BB;So;Cytokine Growth Factor Rev,2008
5. Development of type 1 diabetes mellitus in nonobese diabetic mice follows changes in thymocyte and peripheral T lymphocyte transcriptional activity;Fornari;Clin Dev Immunol,2011
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Identification of Immune Gene Signature Associated with T Cells and Natural Killer Cells in Type 1 Diabetes;Diabetes, Metabolic Syndrome and Obesity;2024-08
2. The OX40/OX40L Axis Regulates T Follicular Helper Cell Differentiation: Implications for Autoimmune Diseases;Frontiers in Immunology;2021-06-21
3. Enhancement of the Soluble Form of OX40 and OX40L Costimulatory Molecules but Reduction of the Membrane Form in Type 1 Diabetes (T1D);Journal of Immunology Research;2019-08-01
4. Relative Expression of OX40, OX40L mRNA, and OX40L Serum Levels in Women with Recurrent Spontaneous Abortion;Immunological Investigations;2019-02-22
5. Therapeutic potential of anti-CD137 (4-1BB) monoclonal antibodies;Expert Opinion on Therapeutic Targets;2015-10-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3